ARCHIVES

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

This article is from The Cancer Letter archive.

Vol. 33 No. 09 | March 9, 2007

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Urges Greater Emphasis On Prevention.

September 21, 2007

New Surgery Grant Applications To Be Reviews By Special Ad Hoc Study Section; 54 Submitted

June 22, 1979

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

How Much Is Life Worth? The $440 Billion Question

July 31, 2009